BOSTON — CVS and Walgreens will begin offering the single-dose Johnson and Johnson vaccine in their pharmacies this week. The vaccine’s use was paused for 11 days so drug regulators could research a series of rare blood clots that occurred in women shortly after they received the vaccine.
“We continue to gather more information from the CDC, and we plan to make J&J vaccines available early next week,” Walgreens representative Rebekah Pajak told Boston 25 News on Saturday.
CVS representative Tara Burke said it would also begin making appointments available this week at stores currently holding Johnson & Johnson COVID-19 vaccine.
“All warnings and precautions will be appropriately communicated throughout the vaccination process,” Burke said.
The doses will now include a warning label noting the risk for extremely rare – but potentially deadly – blood clots.
Last week, the Centers for Disease Control and Prevention revealed 15 women between the ages of 18 and 59 experienced blood clots within six to 15 days after receiving the Johnson and Johnson vaccine.
Three of the women died.
The CDC determined the risk of the clots occurring in women younger than 50 is about seven cases per one million vaccines, and the risk of the clots occurring in women older than 50 is about one in a million.
Massachusetts is set to receive 4,000 doses of the Johnson and Johnson vaccine this week, and there are currently 6,000 doses in reserve. State officials said the doses will likely arrive on Wednesday.
Download the free Boston 25 News app for up-to-the-minute push alerts